163 related articles for article (PubMed ID: 9297069)
21. [Advances in the topical steroid treatment of inflammatory bowel diseases].
Díaz Blasco J; Robledo Andrés P
Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
[No Abstract] [Full Text] [Related]
22. Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Z Gastroenterol; 1995 May; 33(5):247-50. PubMed ID: 7610691
[TBL] [Abstract][Full Text] [Related]
23. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
[TBL] [Abstract][Full Text] [Related]
24. Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands.
Gherardi A; Roze S; Kuijvenhoven J; Ghatnekar O; Yip Sonderegger YL
J Med Econ; 2018 Sep; 21(9):869-877. PubMed ID: 29857775
[TBL] [Abstract][Full Text] [Related]
25. Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?
Teshima C; Fedorak RN
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S216-8. PubMed ID: 18816775
[No Abstract] [Full Text] [Related]
26. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
Creed TJ; Probert CS; Norman MN; Moorghen M; Shepherd NA; Hearing SD; Dayan CM;
Aliment Pharmacol Ther; 2006 May; 23(10):1435-42. PubMed ID: 16669958
[TBL] [Abstract][Full Text] [Related]
27. Review article: older systemic and newer topical glucocorticosteroids and the gastrointestinal tract.
Thiesen A; Thomson AB
Aliment Pharmacol Ther; 1996 Aug; 10(4):487-96. PubMed ID: 8853752
[TBL] [Abstract][Full Text] [Related]
28. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.
Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R
Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348
[TBL] [Abstract][Full Text] [Related]
29. A budesonide prodrug accelerates treatment of colitis in rats.
Cui N; Friend DR; Fedorak RN
Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
[TBL] [Abstract][Full Text] [Related]
30. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.
Lémann M; Galian A; Rutgeerts P; Van Heuverzwijn R; Cortot A; Viteau JM; Elewaut A; Belaiche J; Froguel E; Modigliani R
Aliment Pharmacol Ther; 1995 Oct; 9(5):557-62. PubMed ID: 8580278
[TBL] [Abstract][Full Text] [Related]
31. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
32. Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
Hartmann F; Stein J;
Aliment Pharmacol Ther; 2010 Aug; 32(3):368-76. PubMed ID: 20491741
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
[TBL] [Abstract][Full Text] [Related]
34. Efficiency of inhaled versus oral steroid treatment of chronic asthma.
Toogood JH
N Engl Reg Allergy Proc; 1987; 8(2):98-103. PubMed ID: 3475564
[TBL] [Abstract][Full Text] [Related]
35. Severe complications of ulcerative colitis after high-dose prednisolone and azathioprine treatment.
Matsuda K; Watanabe T; Abo Y; Uchida H; Kawamura YJ; Masaki T; Muto T
J Gastroenterol; 1999 Jun; 34(3):390-4. PubMed ID: 10433019
[TBL] [Abstract][Full Text] [Related]
36. Pulse steroids as induction therapy for children with ulcerative colitis.
Kudo T; Nagata S; Ohtani K; Fujii T; Wada M; Haruna H; Shoji H; Ohtsuka Y; Shimizu T; Yamashiro Y
Pediatr Int; 2011 Dec; 53(6):974-9. PubMed ID: 21624004
[TBL] [Abstract][Full Text] [Related]
37. Budesonide for the treatment of ulcerative colitis.
Abdalla MI; Herfarth H
Expert Opin Pharmacother; 2016 Aug; 17(11):1549-59. PubMed ID: 27157244
[TBL] [Abstract][Full Text] [Related]
38. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192
[TBL] [Abstract][Full Text] [Related]
39. Budesonide and nasal histamine challenge.
Pipkorn U
Allergy; 1982 Jul; 37(5):359-63. PubMed ID: 7125153
[TBL] [Abstract][Full Text] [Related]
40. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
Morice AH; Morris D; Lawson-Matthew P
Clin Pharmacol Ther; 1996 Dec; 60(6):675-8. PubMed ID: 8988070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
